Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole dosing frequency in pediatric perforated appendicitis
NCT02561117Phase 4Withdrawn
- Start
- Jan 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of metronidazole in appendicitis (2 arms). Primary endpoint: Length of hospital stay. Planned start Jan 2019; status: withdrawn.
02
Drugs
metronidazole
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT02561117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02561117.